Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-17216498 in Narcolepsy
NCT00424931Phase 2Completed
- Sponsor
- ALZA Corporation
- Start
- Jan 2007
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of JNJ-17216498 in narcolepsy, sponsored by ALZA Corporation. Started Jan 2007; status: completed.
02
Drugs
JNJ-17216498
03
Conditions
narcolepsy
Beyond the preview
Go deeper on NCT00424931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424931.